Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132553) titled 'Real-World Study of Filsuvez(R) (Betulinic Acid Triterpene Gel) for the Treatment of Chinese Patients with Inherited Epidermolysis Bullosa' on Sept. 15.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Hainan Women and Children's Medical Center
Condition:
Hereditary Epidermolysis Bullosa
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-06-13
Target Sample Size: Observational group:10;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=334216
Published by HT Digital Content Services with permission fro...